| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |